Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;9(3):634-46.
doi: 10.1038/mi.2015.87. Epub 2015 Sep 9.

The local environment orchestrates mucosal decidual macrophage differentiation and substantially inhibits HIV-1 replication

Affiliations
Free article

The local environment orchestrates mucosal decidual macrophage differentiation and substantially inhibits HIV-1 replication

H El Costa et al. Mucosal Immunol. 2016 May.
Free article

Abstract

Macrophages from the decidua basalis (dM), the main uterine mucosa during pregnancy, are weakly permissive to HIV-1 infection. Here, we investigated the mechanisms underlying this natural control. We show, by using freshly purified decidual macrophages and ex vivo human decidual explants, that the local decidual environment influences dM differentiation and naturally protects these cells from HIV-1 infection. Interferon (IFN)-γ, present in the decidual tissue, contributes to maintenance of the dM phenotype and restricts HIV-1 infection by mechanisms involving the cyclin-dependent kinase inhibitor p21Cip1/Waf1. We also found that activation of Toll-like receptors 7 and 8 expressed by dM reinforces the low permissivity of dM to HIV-1 by restricting viral replication and inducing secretion of cytokines in the decidual environment, including IFN-γ, that shape dM plasticity. A major challenge for HIV-1 eradication is to control infection of tissue-resident macrophages in the female reproductive tract. Our findings provide clues to the development of novel strategies to prevent HIV-1 macrophage infection.

PubMed Disclaimer

References

    1. Front Microbiol. 2014 Jul 01;5:316 - PubMed
    1. F1000Prime Rep. 2014 Mar 03;6:13 - PubMed
    1. Nat Immunol. 2010 Oct;11(10):889-96 - PubMed
    1. J Clin Invest. 2012 Mar;122(3):787-95 - PubMed
    1. Retrovirology. 2011 Jul 18;8:58 - PubMed

Publication types